Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2003
08/13/2003EP0914096B1 Microparticles and their use in wound therapy
08/13/2003EP0840570B1 Apparatus and method for making gas-filled vesicles of optimal size
08/13/2003EP0812213B1 Gel form of a vaccine
08/13/2003EP0789587B1 Combined meningitis vaccine
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0470128B2 Active carbonates of polyalkylene oxides for modification of polypeptides
08/13/2003CN1436195A Integrin binding peptide derivatives
08/13/2003CN1436077A Stabilized pharmaceutical compositions contg. calcium channel blockers
08/13/2003CN1436073A Management of snoring by oral administration of dimethyl sulfone
08/13/2003CN1436047A Compositions and methods for improving vascular health
08/13/2003CN1435261A Thermosetting medical carrier composition with mucosa adsorption
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/13/2003CN1117567C Paroxetine controlled release compositions
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/13/2003CN1117565C Stable anti-racemic medicinal preparation of cilancetlone
08/12/2003US6605751 Silver-containing compositions, devices and methods for making
08/12/2003US6605613 Polyene macrolide antibiotic, especially a rapamycin, and an antioxidant, especially 2,6-di-t-butyl-4-methylphenol; 40-O-(2-hydroxy)ethyl-rapamycin in crystalline form.
08/12/2003US6605594 Aqueous glycerol formulations of somatotropin
08/12/2003US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins
08/12/2003US6605303 Oral pharmaceutical extended release dosage form
08/12/2003US6605300 Oral pulsed dose drug delivery system
08/12/2003US6605299 Releasable linkage and compositions containing same
08/12/2003US6605298 Drug delivery
08/12/2003US6605296 Natural substances based agent
08/12/2003US6605295 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
08/12/2003US6605273 Renal cell carcinoma treatment
08/12/2003US6605255 Kit comprising a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, and a means for the determination of the concentration of repinotan or its metabolites in body
08/12/2003US6604698 Forming a dispersion of solid particles of a milled substrate in a fluid carrier comprising providing large size milling media and small size milling media, a conglomerate of solid comprising a substrate to be milled, milling, separating
08/12/2003CA2296373C Composition and method for treating penile erectile dysfunction
08/12/2003CA2286126C Pharmaceutical compositions
08/12/2003CA2101246C Polyose/fatty acid complex product with a high fatty acid content, use as an emulsifier or moisturizer and emulsifying or moisturizing composition in which it is present
08/07/2003WO2003064665A2 Viral vector
08/07/2003WO2003064619A2 Long-acting hormone and growth factor compositions and uses thereof
08/07/2003WO2003064614A2 Transport peptides and uses therefor
08/07/2003WO2003064609A2 Targeted immunogens
08/07/2003WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003WO2003064496A2 Biodegradable polymer
08/07/2003WO2003064462A1 Peg-binding pth or peg-binding pth derivative
08/07/2003WO2003064459A1 Peptides for increasing transfection efficiency
08/07/2003WO2003064454A1 Fap-activated anti-tumor compounds
08/07/2003WO2003064449A2 Bioactive keratin peptides
08/07/2003WO2003064409A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003WO2003063911A1 Decoy-containing pharmaceutical compositions and method of using the same
08/07/2003WO2003063910A2 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER
08/07/2003WO2003063909A1 Responsive microgel and methods related thereto
08/07/2003WO2003063868A1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
08/07/2003WO2003063856A1 Jelly preparation containing branched amino acids
08/07/2003WO2003063855A1 Chewable tablet containing branched amino acids
08/07/2003WO2003063854A1 Chewable tablet containing branched amino acids
08/07/2003WO2003063848A1 Lutein/zeaxanthin for glare protection
08/07/2003WO2003063843A1 Composition for inhalation
08/07/2003WO2003063842A1 Composition for inhalation
08/07/2003WO2003063841A1 Cyclosporin-containing sustained release pharmaceutical composition
08/07/2003WO2003063840A2 Transmucosal delivery of proton pump inhibitors
08/07/2003WO2003063839A1 Bioadhesive composition comprising a polysaccharide and a polycarboxylated polymer
08/07/2003WO2003063838A1 Dry granulated formulations of azithromycin
08/07/2003WO2003063837A1 Increased-dosage nelfinavir tablet and method of making same
08/07/2003WO2003063836A1 Stable pharmaceutical composition comprising pravastatin sodium
08/07/2003WO2003063834A1 Multi-stage oral drug controlled-release system
08/07/2003WO2003063833A1 Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
08/07/2003WO2003063832A1 Pharmaceutical compositions comprising a solid amorphous dispersion of cholesteryl ester transfer protein inhibitors
08/07/2003WO2003063831A2 Immediate release dosage forms containing solid drug dispersions
08/07/2003WO2003063830A1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use
08/07/2003WO2003063827A1 Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol)
08/07/2003WO2003063826A2 Ophthalmic compositions including oil-in-water emulsions, and methods for making and using the same
08/07/2003WO2003063824A2 Pharmaceutical composition
08/07/2003WO2003063823A2 Osmotic delivery system
08/07/2003WO2003063822A2 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
08/07/2003WO2003063821A2 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
08/07/2003WO2003063799A2 Compositions and methods for systemic inhibition of cartilage degradation
08/07/2003WO2003063790A2 Additives and products including oligoesters
08/07/2003WO2003063772A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003WO2003063616A1 Use of multi-layer pigments in the food and pharmaceutical industry
08/07/2003WO2003063603A1 Hard sugar coated preparations, sugar coating solutions and process for producing hard sugar coated preparation
08/07/2003WO2003052091A8 Growth factor modified protein matrices for tissue engineering
08/07/2003WO2003035002B1 Management of postoperative pain
08/07/2003WO2003032728A8 Methods for preventing or reversing asthma and compositions useful therefor
08/07/2003WO2003030829A3 Liposome-encapsulated insulin formulations
08/07/2003WO2003028662A3 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
08/07/2003WO2003011212A3 Biodegradable polyhydric alcohol esters
08/07/2003WO2002098364A3 Magnetic-nanoparticle conjugates and methods of use
08/07/2003WO2002096948A3 Engineered tetravalent antibodies and methods of use
08/07/2003WO2002058736A3 Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis
08/07/2003WO2002004015A9 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
08/07/2003US20030149383 Patch containing anti-inflammatory agent
08/07/2003US20030149296 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery
08/07/2003US20030149246 Macromolecular conjugates and processes for preparing the same
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030149173 Crosslinked polymer compositions and methods for their use
08/07/2003US20030149128 Stabilized monomer adhesive compositions
08/07/2003US20030149111 For therapy of diabetes, hyperglycemia
08/07/2003US20030149106 For use in moisturizing compositions (e.g., moisturizing skin treatments) to which medical adhesives will adhere, in tissue antiseptic preparations, in personal care forumulation such as cosmetics, and in drug delivery forumulations
08/07/2003US20030149102 Combining ascorbic acid and at least one partially or totally crosslinked, solid elastomeric organopolysiloxane
08/07/2003US20030149100 Clear micellized formulations of beta-carotene and method of treating leukoplakia
08/07/2003US20030149097 Storage-stable compositions of glycerol monoalkyl ethers
08/07/2003US20030149075 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003US20030149069 Tetrahydroquinoline derivatives that are useful for cancer chemotherapy and anti-viral applications
08/07/2003US20030149007 For inducing bronchodilation or providing relief of bronchospasm
08/07/2003US20030148996 For therapy of undesirable or uncontrolled cell proliferation
08/07/2003US20030148985 Methods and reagents for the inhibition of hepatitis B virus replication
1 ... 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 ... 1712